ICER is hosting a 3-part colloquium series to complement its recent white paper on alternative approaches for pricing COVID-19 treatments and vaccines.
The first session, which is scheduled to begin noon EST Friday, will focus on a cost-recovery pricing model.
The second installment, which will cover cost-effectiveness and value-based pricing, is set for noon EST July 31. The last session will spotlight models that focus on monetary prizes, compulsory licensing and advanced market commitments is slated for noon EST Aug. 7.
For more information about the first session, click here.